한국어
English
日本語
中文(简体)
Hyjoshin Tablet 2mg (Terazosin Hydrochloride Hydrate)
2.374mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.
Terazosin hydrochloride hydrate is a component that relaxes the urethra and bladder muscles for the treatment of benign prostatic hyperplasia.
MFDS ingredient code M256626
Terazosin hydrochloride hydrate is a medication belonging to the alpha-1 adrenergic receptor blocker class. It is primarily used to improve urinary disorders caused by benign prostatic hyperplasia. This ingredient relaxes the smooth muscles of the urethra and bladder, facilitating urine discharge.
Terazosin hydrochloride hydrate blocks the alpha-1 receptors in the urethra and bladder, causing muscle relaxation. This results in a widening of the urethra, allowing urine to be expelled easily. Consequently, discomfort during urination and retention phenomena are reduced.
Approved uses differ by product. Check each product's information for its actual use.
Terazosin hydrochloride hydrate has a blood pressure-lowering effect compared to other alpha-1 blockers, but it is effective in improving urological symptoms. Additionally, its hydrate form enhances stability, facilitating absorption in the body.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.